We're working on a new version of PRX. Want a sneak peek?

Kristin Espeland Gourlay

User image
My vCard
  • Username: kespeland
  • Health care reporter
  • Role: Producer/Reporter: Station-Based

Portfolio

Caption: Bottle of oxycodone pills, Credit: Kristin Gourlay

Killer Drugs: Tackling Opioid Addiction and Overdose (56:57)
From: Kristin Espeland Gourlay

Prescription painkillers like OxyContin have flooded the market. They're incredibly addictive, and once people are hooked, the habit gets expensive. More and more are turning ...
Caption: Baby Jonathan, 10 days old, Credit: Kristin Gourlay

Her Newborn In Withdrawal, A Young Mother Faces Her Own Recovery (06:47)
From: Kristin Espeland Gourlay

More babies are being born dependent on the opioid drugs their pregnant mothers were taking. Their condition, called neonatal abstinence syndrome, sometimes requires hospital ...
Caption: Rapid screening test for hepatitis C infection, Credit: Kristin Gourlay

At the Crossroads, Part 1: A Tale of Two Epidemics (07:55)
From: Kristin Espeland Gourlay

Baby boomers make up the majority of the estimated five million people who have hepatitis C. Most caught the disease – from sharing needles, or a blood transfusion - years ...
Piece image

At The Crossroads, Part 2: Finding Hep C Infections Before It's Too Late (06:43)
From: Kristin Espeland Gourlay

How do you stop an epidemic? Keep the people who are sick from infecting more people. Isolate them if you have to, treat them, and cure them. Epidemic over. But what if you ...
Piece image

At The Crossroads, Part 3: As Old Hepatitis C Treatment Fades Out, New Treatments Stoke Hope (07:52)
From: Kristin Espeland Gourlay

In just a few weeks, another pharmaceutical company will likely win FDA approval for a new drug to cure hepatitis C. That makes three breakthrough medications hitting the ...